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Picornaviruses encode for and require a viral RNA-dependent RNA polymerase 
(RdRP) for genome replication. This enzyme synthesizes negative-sense RNA from the 
infecting positive sense genome producing a replicative intermediate. The negative sense 
RNA then serves as a template for synthesis of additional positive-sense RNA. To 
efficiently replicate the genome, RdRPs must form a stable and processive elongation 
complex (EC) by binding RNA, incorporating the first templating nucleotide, and 
undergoing a necessary conformational. Upon completion of these steps that comprise 
initiation, the newly formed EC is capable of rapidly replicating the viral genome. The 
work presented in this thesis 1) investigates the role that several basic and hydrophobic 
residues serve in forming and maintaining the poliovirus (PV) EC and 2) presents the 
crystal structure of a coxsackievirus (CV) EC. To determine the role of that several 
arginines, lysines, and tyrosines play in the PV polymerase, we assessed whether 
mutations to these residues affect initiation, elongation, or stability of the EC. The data 
indicates the basic residues within the fingers domain of the PV polymerase have a major 
role in binding RNA. In addition, data shows two tyrosine residues in particular are 
critical for formation and maintenance of the EC. Overall, the data provides evidence the 
fingers domain interacts with the template RNA in a manner not captured by crystal 
structures. Finally, we have solved the structure of a CVEC stalled after incorporation of 
four nucleotides. The CVEC structure closely matches the previously solved PVEC 
structure. In addition, one crystal form produced an elongation complex trapped in a 
translocation intermediate state.  
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1.1 Picornavirus Overview and History 
Members of the Picornaviridae family of viruses contain a single-stranded positive-sense 
RNA genome between 6500 and 9500 nucleotides in length packaged within a small (~ 30 nm) 
non-enveloped icosahedral capsid. The family can be broken into twelve different genera, and 
contains many animal and human pathogens. Examples of medically relevant viruses within this 
family include poliovirus, coxsackievirus, rhinovirus, foot and mouth disease virus, and Hepatitis 
A virus. Due to the health implications associated with picornaviruses, a significant amount of 
research has gone into understanding the mechanisms by which they cause disease. In fact, much 
of our knowledge regarding viral processes has arisen from studying picornaviruses. In 1898, 
foot and mouth disease virus became the first identified animal virus (Loeffler and Frosch, 
1964), with the discovery of poliovirus following ten years later (Landsteiner and Popper, 1908). 
The plaque assay, used throughout virology to quantify viral infectivity (Dulbecco, 1952), and 
the first infectious DNA clone of an animal virus were developed using poliovirus (reviewed in 
Racaniello, 1981). In addition, the first three-dimensional structures of virions were determined 
through X-ray crystallography studies on poliovirus and rhinovirus (Hogel et al., 1985; 
Rossmann et al., 1985). In general, poliovirus has become the prototypical virus to study in this 
family, due mainly to the historical impact of the virus.  
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 The first significant outbreak of poliomyelitis in the United States occurred in 1894 
(World Health Organization, 2010). After the initial outbreak, polio prevalence grew continually 
both in the United States as well as the rest of the world. In 1916, poliovirus became an epidemic 
in New York, leading to many seasonal national epidemics that peaked during the 1950’s. These 
epidemics stimulated research that culminated in the development of two polio vaccines: the 
inactivated polio vaccine (IPV) by Salk and Youngner (Salk et al., 1954) and the oral polio 
vaccine (OPV) by Sabin (Sabin et al., 1960). The IPV employs chemically killed virus to provide 
immunity, while the OPV presents an attenuated virus. The two vaccines proved very effective in 
combating the epidemic and significantly reduced the number of cases occurring each year. 
However, a lack of consistent immunization hindered progress towards eliminating the threat so 
that in 1988 poliovirus still caused over 350,000 worldwide cases of paralysis every year. This 
prompted the World Health Assembly to launch resolution 41.28: The Global Polio Eradication 
Initiative with the resolve to eradicate polio from the planet by the year 2000. 
The initiative led to a dramatic reduction in the number of cases occurring each year so 
that by 1994 the United States was declared polio-free and, by 2002, half of the world’s 
population lived in polio-free regions (World Health Organization, 2010). Success stemmed 
from the combination of the two vaccines and efficient diagnostic techniques for detecting 
poliovirus within populations. However, approximately 1500 cases of poliomyelitis still occur 
worldwide every year. In addition, wild poliovirus remains endemic in four countries: 
Afghanistan, India, Nigeria, and Pakistan (World Health Organization, 2010). The eradication 
effort faces primarily political struggles in these countries. However, another issue stems from 
the live attenuated OPV’s ability to revert back to wild-type infectiousness resulting in vaccine-
derived poliovirus (VDPV). As a result, the OPV, which provides immunity in underdeveloped 
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countries, is an additional source for poliovirus infection. Cases of VDPV have been reported in 
several areas, including China, Hispaniola, the Philippines, and Madagascar (World Health 
Organization, 2010). While the IPV circumvents this problem, the vaccine is far more expensive 
than the OPV and requires a trained health professional for administration, making it less 
suitable for underdeveloped countries. The weaknesses associated with each vaccine necessitate 
continued efforts to develop new antivirals and better vaccines.  
1.2 Viral Life Cycle 
1.2.1 Infection and Cell Entry 
Poliovirus, a member of the enterovirus genus, spreads primarily through fecal-oral 
transmission. Once contracted, viral replication occurs in the upper gastrointestinal tract, 
specifically within the oropharyngeal and intestinal mucosa of the human host (Bodian and 
Hortsmann, 1965; Sabin, 1956). After multiplication, viral particles pass into the lymph nodes 
from which they eventually enter the bloodstream, causing a transient viremia (Fig. 1.1) (Bodian 
and Hortsmann, 1965). Most cases of poliovirus infection lead to nonspecific symptoms 
including fatigue, headache, fever, sore throat, and malaise. However, in rare instances (<1%), 
the virus enters the central nervous system (CNS), infecting and destroying the motor neurons 
within the brain stem or spinal cord and results in the characteristic paralytic poliomyelitis.  
Viral entry into host cells is mediated by interactions with the poliovirus receptor (PVR), 
CD155. This integral membrane protein is a member of the immunoglobulin (Ig) super family of 
proteins and contains three Ig-like domains (Mendelsohn et al., 1989). In host cells, CD155 
interacts with Nectin-3, a member of a family of adhesion molecules that interacts with cadherin 
to form and stabilize cell-cell adherens junctions that mediate cell-cell adhesion (Mueller and 
3
FIG 1.1 Postulated pathway for poliovirus infection. The virus begins replicating in the upper 
gastrointestinal tract and reaches the bloodstream through the lymph nodes, resulting in a primary 
viremia. In some instances, poliovirus continues on to the motor neurons, leading ultimately to 
paralysis. In most cases, the virus spreads through fecal-oral contamination, but may also be spread 
through the respiratory route (from Racaniello, 2005).       
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Wimmer, 2003). Upon binding to CD155, the poliovirus internalizes through an actin- and 
receptor tyrosine kinase dependent manner and releases the genome from the vesicle within the 
first 100-200 nm of the cytosol (Fig. 1.2) (Brandenburg et al., 2007).  
 Closely related to poliovirus, coxsackievirus B3 (CVB3) is another enterovirus that 
presents a threat to human health. Scientists first isolated CVB3 as poliovirus, only later to find 
distinctions between the two. CVB3 spreads through fecal-oral contamination and follows a 
similar path of infection as poliovirus. In most cases, CVB3 infection produces only mild 
symptoms such as diarrhea, headache, and fever. However, CVB3 infection within heart cells 
causes myocarditis and can lead to cardiomyopathies (Beck et al., 1990; Esfandiarei and 
McManus, 2008). CVB3 infects approximately 20,000 individuals each year in the US, of which 
between 10-20% will develop chronic myocarditis (reviewed in Kim and Nam, 2010). Despite 
all of this, no CVB3-specific vaccine exists at this time. 
Upon infection, CVB3 binds to host cells through interactions with the coxsackievirus 
and adenovirus receptor (CAR), allowing for viral entry (Bergelson et al., 1997). Since CAR 
resides in the tight junctions, rather than the apical surface of epithelial cells, CVB3 cannot 
immediately bind the receptor. Therefore, CVB3 must bind to the GPI anchored protein CD55, a 
decay-accelerating factor (DAF) (Shafren et al., 1995). Binding activates AB1kinase, which in 
turn triggers Rac-dependent actin rearrangements, allowing for the virus to move to the tight 
junction. In addition, DAF facilitates activation of Fyn kinase, an essential enzyme for the 
formation of caveolar vesicles that are responsible for endocytosis of the CVB3 (Coyne and 
Bergelson, 2006). The mechanism of cell entry highlights one key difference between CVB3 and 
poliovirus; however, once the viral genome is inserted into the cell, both viruses employ nearly 
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FIG 1.2 Poliovirus entry into host cells. Upon binding to CD155, the virus is internalized in actin- 
and receptor tyrosine kinase-dependent manner. The viral genome is released within the first 
100-200nm from the plasma membrane, after which the capsid is transported along microtubules (from 




identical means for replication and production of virions. Therefore, this chapter will focus 
primarily on poliovirus, the prototypical enterovirus, due to the substantial amount of 
information and research available on poliovirus replication.  
1.2.2 Viral Genome and Translation 
Picornaviral genomes consist of three basic components: the 5’ untranslated region 
(5’-UTR), the coding region, and the 3’ untranslated region (3’-UTR) (Fig. 1.3A). The 5’-UTR 
contains substantial secondary structures that play crucial roles in both translation and replication 
of the viral genome. Of the six stem loop structures present in the 5’-UTR, the first forms a 
cloverleaf comprised of three small stem-loops that interact with various proteins to direct 
replication (Rivera et al., 1988; Andino et al., 1990). The other five stem-loops constitute the 
internal ribosome entry site (IRES) allowing for cap-independent translation (Jang et al., 1988; 
Pelletier and Sonenberg, 1988; Fitzgerald and Semler, 2009). The 3’-UTR (~70 nucleotides in 
poliovirus) is relatively small compared to the 5’-UTR (~740 nucleotides in poliovirus), but also 
contains secondary structures that mediate RNA-RNA interactions to form a tertiary pseudoknot 
structure that is important for RNA syntheses (Jacobson et al., 1993). In addition, the 3’-UTR of 
both virion RNA and mRNA contain a poly(A) tail with an average length of 60 nucleotides in 
poliovirus (Yogo and Wimmer, 1972). 
Upon insertion of the positive-sense viral genome, translation is carried out by host cell 
machinery that recognizes the IRES and, in turn, produces all the necessary viral proteins 
(Fig. 1.4) The absence of the 7-methyl guanosine cap typically found on cellular mRNAs, which 
initiates canonical cap-dependent translation through binding of translation initiation factor eIF-
4F (Merrick, 1990), necessitates this alternative mechanism for initiation (Fig. 1.5). Picornaviral 
7
FIG 1.3 Structural organization of the poliovirus RNA genome and proteolytic processing. (A) 
The 5’NTR consists of substantial amounts of secondary structure, including the IRES element 
necessary for translation initiation. In addition, VPg is covalently linked to the 5’ end of the genome to 
prime replication. The 3’ NTR  displays additional secondary structure as well as the poly(A) tail. 
Sandwiched in the middle is the single open reading frame comprised of eleven gene products. (B) The 
single open reading frame generates a 247kDa protein upon translation, which is subsequently cleaved 
by viral proteases into functional intermediates and mature proteins (from De Jesus, 2007).	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FIG 1.4 Picornaviral Life-Cycle. Diagram illustrating the typical life-cycle for picornaviruses. Upon 
infection, the genome is translated by the host cell protein synthesis machinery to generate functional 
intermediates and mature protein products. Non-structural proteins then carry out replication of the 
viral genome to produce large numbers of viral RNA that not only serve in additional rounds of 




FIG 1.5 Translation initiation mechanisms. (A) Eukaryotes employ several initiation factors that 
recognize the 5’ cap of mRNA in order to recruit ribosomes. (B) Poliovirus, which lacks the 5’ cap, 
utilizes substantial secondary structure within the IRES to mediate ribosome recruitment. Currently, 
scientists believe this process is mediated by additional proteins thereby preventing direct interactions 
between the RNA and ribsome complex (Fitzgerald and Semler, 2009).
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RNA molecules have VPg (virion protein, genome linked) covalently attached to their 5’ ends, 
which must be cleaved by host cell proteases from the genome before translation can proceed 
(Nomoto et al., 1977; Ambros and Baltimore, 1980; Ambros et al., 1978). This cap-independent 
translation initiation is mediated by the binding of several canonical and non-canonical 
translation factors, such as poly(rC) binding protein 2 (PCBP2), to the stem-loop structures 
within the 5’-UTR (Sean and Semler, 2009). The translation factors serve to recruit host cell 
translation machinery to viral genome. To inhibit host cell translation, the viral proteinase 2A 
cleaves poly(A)-binding protein (PABP) (Joachims et al., 1999) and eIF4G, which is a 
component of eIF-4F formerly known as p220 (Krausslich et al., 1987). In addition, viral 
proteinase 3C inhibits host cell transcription of additional mRNA molecules by inactivating 
transcription factor TFIIIC (Clark et al., 1991) and cleaving TATA-binding protein (TBP) 
thereby, preventing the formation of TBP-TATA box complex (Yalamanchili et al., 1996). 
1.2.3 Proteolytic Processing 
Translation of the single open reading frame (ORF) of the viral genome generates a 247 
kDa polyprotein that is subsequently cleaved by viral proteinases (Fig. 1.3B) (Wimmer et al., 
1993). Cleavage produces eleven final viral gene products and several functional intermediates 
that are categorized into three broad groups: P1, P2, and P3. The P1 (VP1-VP4) region encodes 
for four structural proteins that later compose viral capsids while the P2 (2A-2C) and P3 (3A-
3D) regions result in seven non-structural proteins necessary for protein processing and genome 
replication. The cleavage events occur both co- and post-translationally through activity of three 
viral proteinases: 2Apro, 3Cpro, and 3CDpro (Fields 2007).  
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Two primary cleavage events occur co-translationally in cis: 2Apro cleaves between P1 
and P2 (VP1 and 2A), releasing the capsid moieties from the non-structural proteins, and 3Cpro 
cleaves between P2 and P3 at the 2C-3A junction. In poliovirus, 2Apro cleaves at tyrosine-glycine 
residues while 3Cpro cleaves at glutamine-glycine pairs (Fields, 2005). After the initial co-
translational proteolytic cleavage, 2Apro liberates itself from the polyprotein through self-
cleavage to act on host cell proteins (as previously discussed), while 3Cpro cleaves the 3AB-3CD 
junction to generate 3CDpro, which carries out additional in trans cleavage events.   
The three viral proteinases display various levels of catalytic efficiency, depending on the 
environment found at the cleavage sites, such as steric accessibility and the surrounding amino 
acid sequence. The differences in efficiency yield disproportionate amounts of precursor and 
mature proteins throughout the course of the viral infection. The stability and function of many 
of the precursors allows tight control of the progression of the viral life cycle, despite the limited 
coding capacity of the small viral genome. As an example of this concept, the P3 region quickly 
undergoes two initial cleavage events to generate 3AB and 3CD. However, the subsequent 
cleavage of 3AB and 3CD is less efficient, resulting in a slow increase of the mature products 
3A, 3B, 3C, and 3D. This slower pace provides 3CDpro sufficient time to carry out necessary 
cleavage events, such as the processing of the P1 coding sequence to generate the capsid proteins 
VP4, VP3, VP2, and VP1. The importance of this arises from 3CDpro’s increased efficiency for 
cleaving the P1 domain as compared to 3Cpro (Jore et al., 1988; Ypma-Wong et al., 1988). This 
serves as direct evidence for the importance of differences in cleavage efficiency and how 
proteolysis can regulate protein function.   
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1.2.4 RNA Replication 
Proteolytic processing generates the proteins necessary for viral propagation, including 
one key enzyme responsible for replication of the viral genome: the RNA-dependent RNA 
polymerase (RdRP) known as 3D polymerase (3Dpol) in picornaviruses. This 52 kDa protein 
carries out negative strand synthesis from the infecting genomic RNA and produces positive 
strands (from the negative sense template) that will serve for continued viral protein translation 
and become packaged into new virions. RNA replication occurs in membrane anchored 
replication centers. Viral infection results in the destruction of the endoplasmic reticulum and 
golgi apparatus and the subsequent formation of double-membraned vesicles within the host cell 
(Schlegel et al., 1996). On the cytosolic face of these vesicles, viral proteins 3Dpol, 3CDpro, 3AB, 
and 2C gather to form replication centers and mediate RNA replication (Fig. 1.6) (Egger et al., 
2000). Membrane localization of the necessary viral proteins serves to protect the RNA genome 
from degradation by the host cell and to increase the local concentration of the replication 
machinery, thereby ensuring efficiency in the process (Fields, 2005).  
 To reiterate, negative sense RNA must first be synthesized from the infecting genomic 
RNA before high levels of positive stranded RNA molecules can be produced. However, upon 
insertion of the genome into the cytoplasm, host cell ribosomes bind and translate the RNA, a 
process that polymerase is unable to disrupt (Barton, 1999). Therefore, the virus switches from 
translation to replication through the buildup of viral protein 3CDpro, which serves not only as a 
protease, but also as an RNA binding protein (Andino et al., 1990). 3CDpro binds to the 
5’-cloverleaf structure and inhibits translation by preventing binding of the host cell translational 
machinery, namely eIF4G, and thereby allowing for replication to occur (Gamarnik and Andino, 
13
FIG 1.6 Four-step model for asymmetric replication of poliovirus RNA. (A) Initiation of negative-
strand RNA synthesis to generate the replicative intermediate(first step); (B) initiation of VPg 
uridylylation using the cre element (second step); (C) termination of VPg Uridylylation(third step); (D) 
initiation of positive-strand RNA synthesis (fourth step) (from Murray and Barton, 2003). 
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1998). The current model suggests 3CD mediates circularization of the genome through an 
RNA-protein-protein-RNA interaction that draws the 5’-cloverleaf and 3’-stem loop together 
through interactions with cellular poly(C) binding protein 1 (PCBP1) and poly(A) binding 
protein (PABP) in a ribonucleoprotein complex (Fig. 1.6) (Herald and Andino, 2001). Genome 
circularization not only prevents further host cell translation, but also must occur for RNA 
replication to proceed (Herald and Andino, 2001; Lyons et al., 2001). In addition, 2Apro, which is 
required for increased RNA stability, may stimulate negative-strand synthesis (Jurgens, 2005). 
 Similar to other polymerases, picornaviral RdRPs require a primer for initiation of 
replication (Flanegan and Baltimore, 1977). Previous studies have demonstrated the viral 
genome as well as newly synthesized plus and minus strand RNA are covalently linked to VPg, a 
22 amino acid peptide corresponding to 3B (Nomoto et al., 1977). The subsequent model for 
initiation of both positive and negative strand synthesis includes VPg as the primer for 3Dpol 
(Wimmer, 1982). Interestingly, poliovirus-infected cells contain VPg as well as an uridylylated 
form: VPg-pUpU (Crawford and Baltimore, 1983). Uridylylation of VPg occurs at tyrosine 3 and 
is catalyzed by 3Dpol (Paul et al., 1998). The various forms of VPg allow for differentiation 
between positive and negative strand syntheses. The hydroxyl group of Tyr3 in VPg serves to 
prime negative strand synthesis while VPg-pUpUOH primes positive strand initiation. (Fig. 1.6) 
(Murray and Barton, 2003). The initial study showing 3Dpol catalyzes the uridylylation reaction 
also demonstrated the necessity of a poly(A) template, suggesting that the 3’poly(A) tail of 
positive sense RNA serves as the template for uridylylation of at least minus strand synthesis 
(Paul et al., 1998). However, a cis-replicating element (cre) within the 2C coding region of the 
ORF displays a conserved 5’-AAAC-3’ sequence within a stem loop (Yang et al., 2004) that 
templates uridylylation with greater efficiency than a poly(A) oligomer (Paul et al., 2000; Rieder 
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et al., 2000). Furthermore, mutating the cre abolishes the formation of VPg-pUpU despite the 
presence of a poly(A) tail. This led to a model that employs cre for templating uridylylation, 
rather than the poly(A) tail at the 3’NTR to allow for positive strand initiation (Fig. 1.6)(Murray 
and Barton, 2003). The use of the cre to initiate replication serves to ensure replication centers 
are composed of viral RNA instead of host mRNA (Paul, 2002). 
 Replication requires genome circularization as mediated by 3CDpro. This process may 
serve to recruit 3AB as another component of the ribonucleoprotein complex (Xiang et al., 
1995). Recruitment would place 3AB in close vicinity to 3CDpro, allowing for the cleavage that 
generates VPg for initiation of negative strand synthesis at the poly(A) tail. Genomic RNA 
isolated from replication centers remains in a duplex known as the replicative form, comprised of 
the complimentary negative and positive sense strands (Baltimore et al., 1964; Barton and 
Flanegan, 1997). Initiation of positive strand RNA synthesis leads to melting of the duplex, 
leaving the negative strand to serve as a replicative intermediate to template additional rounds of 
replication. The buildup of VPg-pUpU primes the synthesis of large levels of positive strand 
resulting in approximately 50,000 copies of positive sense RNA per cell (Fields, 2005). This 
large copy number illustrates the stoichiometric asymmetry of replication in that positive 
stranded RNA molecules outnumber negative sense RNA molecules, which serves as the 
replication intermediate, by 50:1 (Novak and Kirkegaard, 1991). After synthesis, the positive 
stranded RNA can then serve in further rounds of translation to produce additional viral proteins 
for virion production, become replicated to increase levels of negative sense RNA, or packaged 
into virions. 
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1.3 Mechanism and Kinetics of Picornaviral Polymerases 
1.3.1 Polymerase Kinetics 
The RNA-dependent RNA Polymerase (RdRP) that catalyzes the synthesis reaction of 
both negative and positive strand RNA comes from the “D” protein within picornaviral 
polyprotein giving rise to the name 3Dpol. As previously described, in vivo viral genome 
replication occurs in the context of replication centers and requires several additional viral 
enzymes. In order to efficiently study the mechanism of RNA replication by 3Dpol, techniques 
have been developed to allow for replication using purified polymerase without the presence of 
any other viral proteins. Of special significance to this thesis has been the development of self-
priming hairpin RNA constructs known as Primer Elongation Template Elements (PETEs) for 
use in determining the kinetics of 3Dpol (Gong et al., 2009; Mestas et al., 2007). Using PETE 
prevents the need to include a separate primer strand in the reaction, thereby eliminating a 
second 3’-OH inherent with the annealing event and ensures duplex integrity even at lower RNA 
concentrations. Therefore, PETEs have only one priming site for 3Dpol binding and initiation. In 
addition, PETE RNA constructs can be readily modified through the addition of molecular 
probes that allow for either fluorescent or infrared detection (Gong et al., 2009; Mestas et al., 
2007). Using assays that utilize PETE and various other biochemical techniques, a better 
understanding has been developed regarding the three different phases of RNA replication: 
initiation, elongation, and termination.  
 The overall process of initiation involves two discrete steps: the binding event between 
3Dpol and the RNA substrate followed by incorporation of the first nucleotide (Fig. 1.7). 
Initiation results in the formation of an active and stable elongation complex (EC) capable of 
17
FIG 1.7 Kinetic mechanisms for initiation and elongation by 3Dpol. The kinetic mechanism for 
initiation (top) entails three different steps. First, the enzyme (E) binds the RNA (R) substrate (k1) 
followed by a conformational change in the enzyme (k2) and the slow incorporation of the first NTP 
(k3) to form a very stable elongation complex capable of elongating. The kinetic mechanism for 
elongation (bottom) occurs after initiation, and is a five step mechanism, each step is represented by 













open closed closed open stable EC 
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rapidly elongating a template RNA with high processivity. The Cameron lab has performed 
extensive studies in order to characterize the initial binding event. By employing a symmetrical 
primer – template substrate (sym/sub) RNA complex, they found 3Dpol binds RNA substrate 
slowly with an association rate of 0.1 µM-1s-1. Binding is followed by an isomerization event that 
primes the complex for catalytic competence, which occurs with a rate of 0.076 s-1 (Arnold and 
Cameron, 2000).  The 3Dpol-RNA complex dissociates at a rate of 0.1 s-1, with an equilibrium 
dissociation constant in the low µM range, although the latter is dependent upon experimental 
conditions such as pH, temperature, and RNA structure (Arnold and Cameron, 2000; Mestas et 
al., 2007). After binding the RNA primer/template substrate, 3Dpol incorporates the first 
nucleotide with an extremely slow rate of 0.06 s-1 in comparison to subsequent incorporation 
events that occur at a rate of 0.0001 s-1. Although this first incorporation event is ~600-fold 
slower, the resulting EC becomes highly stable with a half-life of 8 h at 22°C (Arnold and 
Cameron, 2000). Upon formation of the EC, the polymerase is poised to rapidly replicate a viral 
RNA genome, suggesting some conformational changes must occur to prime the polymerase for 
genome replication. Despite the availability of a crystal structure of the poliovirus EC, evidence 
for these conformational changes remains undetermined (Gong and Peersen, 2010).  
 Similar to initiation, the overall mechanism of 3Dpol elongation can be dissected into 
discrete steps that constitute a catalytic cycle for incorporation of a single nucleotide (Fig. 1.7). 
The five step cycle includes 1) nucleotide triphosphate binding, 2) a conformational change to 
reposition the NTP for catalysis, 3) catalysis and phosphodiester bond formation, 4) a second 
conformational change and 5) pyrophosphate release and translocation. Of these five steps, 
nucleotide repositioning (2) and catalysis (3) appear to be rate limiting if the complex is provided 
sufficient amounts of nucleotides. To determine the rate of nucleotide incorporation, the Peersen 
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lab has used a PETE RNA construct with a 26-nucleotide template for stopped-flow kinetics 
(Gong et al., 2009). At 37°C and  pH 7.5, PV 3Dpol incorporates approximately 50 nt/sec when 
presented with 120 µM of each NTP. Factoring in increased intracellular NTP concentrations, 
3Dpol would replicate a poliovirus genome of 7500 nucleotides in less than 100 seconds at a rate 
of approximately 70-80 nt/sec (Gong et al., 2009). Although initiation and elongation have been 
well characterized, there is no known mechanism for elongation termination aside from random 
dissociation and runoff of the polymerase from the end of the RNA.  
1.3.2 Polymerase Fidelity  
As is observed in many RNA viruses, 3Dpol fidelity during genome replication is very 
low due to the lack of a proofreading mechanism. In contrast, DNA polymerases have 3’-
exonuclease activity that enables them to correct a nucleotide misincorporation event. Errors 
occur at a frequency of approximately 10-3 to 10-5 per nucleotide incorporated, a value roughly a 
million fold higher than the error frequency approximated for cellular DNA replication (Drake, 
1969; Drake 1993). The high error rate associated with RNA replication suggests that every 
genome contains at least one mutation (Drake and Holland, 1999). Therefore, one infected cell 
generates an assortment of closely related viruses, yielding a diverse population known as a 
quasispecies (Domingo et al., 1997). Generation of a quasispecies allows viral evolution and 
adaptation to selective pressures, such as host cell defense mechanisms (Vignuzzi et al., 2006). 
The error frequency responsible for the quasispecies lies at the threshold of “error catastrophe.” 
Slower error rates prevent viral evolution while faster rates result in a large proportion of non-
viable viruses that prevents propagatation (Crotty et al., 2004). Scientists have exploited this 
feature of viral replication by using a mutagenic nucleotide analogue known as ribavirin to 
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increase error rates past the threshold of error catastrophe (Pfeiffer and Kirkegaard, 2005). This 
small molecule is widely used in experimental studies, but also serves as drug for cobatting viral 
infections, especially hepatitis C. 
1.4 Structure of Picornaviral Polymerases 
1.4.1 Apo PV 3Dpol Structure 
Structurally, poliovirus 3Dpol folds according to the classic analogy of a cupped right 
hand comprised of a palm, thumb, and finger domains, first used to characterize the DNA 
polymerase I Klenow fragment from Escherichia coli (Ollis et al., 1985; Hansen et al., 1997). 
The initial x-ray crystal structure of poliovirus polymerase provided insight into structure-
function relationships; however, the structure contained a disordered fingers domain, thereby 
precluding key information regarding the overall mechanism. To obtain a complete structure, 
Interface I, which entails a head-to-tail oligomerization that may have biological importance in 
membrane-bound replication complexes (Hobson et al., 2001; Lyle et al., 2002), was disrupted 
through point mutations L446D and R455D (Thompson and Peersen, 2004). The resulting 
structure, resolved to 2 Ǻ showed continuous electron density throughout the entire protein 
chain, including the fingers domain (Fig. 1.8A). 
 The core of the palm domain in poliovirus 3Dpol contains four structural motifs that are 
highly conserved in other polymerase structures. The domain consists of four anti-parallel β-
sheets packed above two α-helices resembling an RNA recognition motif (RRM) found in 
various RNA-binding proteins, including ribosomal proteins and splicing proteins (Hansen et al., 
1997). The active site residing within the palm domain consists of a highly conserved YGDD 




FIG 1.8 Structural overview of poliovirus 3Dpol. (A) Top view of the complete 3Dpol structure. The 
structure follows the analogy of primate right hand with the thumb in blue,  the index finger in green, 
the middle finger in orange, the ring finger in yellow, and the pinky finger in pink, and finally the palm 
in gray. (B) Diagram of the amino acid sequence of 3Dpol colored according to the structural elements 
shown in (A). The numbers correspond to the specific residues where domains begin and end (from 
Thompson and Peersen, 2004). 
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Replacing tyrosine 326 with either phenylalanine or methionine yields active polymerase in in 
vitro studies, although only Y326F produces viable viruses in transfection studies (Jablonski et 
al., 1993). Mutation of the conserved glycine residue to either alanine or serine results in reduced 
but definitive activity, while mutagenesis to other residues abolishes enzyme activity (Jablonski 
et al., 1991). Finally, mutation of one or both aspartic acids produces completely inactive 
enzymes, even when mutated to glutamic acid. However, a D329N mutation displays in vitro 
activity in the presence of Mn2+ or Fe2+ instead of Mg2+ as the divalent metal cation (Jablonski et 
al., 1995). Overall, the conservation of the YGDD motif is required for a functional polymerase. 
 In addition to the two aspartates within the active site, Asp233 located on an adjacent β 
strand on the “back” of the palm domain is highly conserved and crucial in the two-metal-ion 
binding mechanism for catalysis (Steitz, 1998). This model involves two divalent metals (A & B) 
that each contributes in a different manner. Metal A serves as a Lewis acid that activates the 
3’-OH group to an O-, which allows for nucleophilic attack on the α-phosphate of the incoming 
rNTP, resulting in phosphodiester bond formation. Metal B coordinates with the β and γ 
phosphates of the triphosphate moiety to hold it in a catalysis competent conformation. The 
conserved Asp residues serve to chelate the two divalent metals required for the phosphoryl 
transfer reaction (Steitz, 1998; Sosunov et al, 2005). 
 The complete poliovirus polymerase structure reveals an enclosed active site formed by 
interactions between the thumb and fingers domain; specifically, phenylalanines 30 and 34 insert 
into a hydrophobic pocket at the top of the thumb (Thompson and Peersen, 2004). This 
interaction creates an NTP entry channel at the back of the polymerase. Furthermore, the 
previously uncharacterized fingers domain is divided by analogy to a primate hand with an index 
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finger (residues 1-68), middle finger (residues 269-285), ring finger (residues 150-179), and 
pinky finger (residues 96-146 and 180-190) (Fig. 1.8B) (Thompson and Peersen, 2004). The 
other unique and highly important feature of the polymerase is the buried N-terminal glycine 
residue in a pocket residing at the base of the fingers domain. This burial functions to properly 
position Asp238 relative to the active site, allowing for hydrogen bonding between the aspartate 
and the 2’OH of incoming NTPs; an important interaction for selecting rNTPs over dNTPs 
(Thompson and Peersen, 2004; Huang et al., 1997). Thus, proteolysis of 3CDpro into mature 
3Dpol serves as an allosteric switch that activates 3Dpol by repositioning Asp238 1.4Å closer to 
the active site relative to the surrounding structure. Mutational analysis of the N-terminal glycine 
shows abolished enzyme activity due to the addition or removal of a single amino acid, and 2- 
and 50-fold decrease for G1A and G1S mutations respectively (Thompson and Peersen, 2004).    
1.4.2 PVEC Structure 
 Recently, the Peersen lab obtained additional insight regarding the mechanism and 
conformational changes that accompany NTP recognition, active site closure, and catalysis 
through co-crystallizing poliovirus 3Dpol with an RNA construct (Fig. 1.9) (Gong and Peersen, 
2010). Using a newly designed experimental approach, they formed a highly stable EC stalled 
four nucleotides into the replication cycle with significant upstream and downstream duplex 
RNA. The structure shows template nucleotides +1, +2 and +3 are single stranded with strand 
separation of the downstream duplex RNA occurring at residues 18 and 19 of the index finger. 
The +2 nucleotide resides in a pocket formed by Pro 20 and the index finger that prevents it from 
base stacking with either the +3 or +1 nucleotides. The +1 nucleotide is positioned within the 
active site to allow for base stacking with the -1 upstream nucleotide and base pairing with the 
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FIG 1.9. Poliovirus 3Dpol-RNA elongation complex structure. The poliovirus polymerase is colored 
with the palm in grey and the thumb in blue while the index, middle, ring and pinky fingers are in 
green, orange, yellow and pink, respectively. The structure shows the template RNA strand in cyan, 
downstream non-template strand in magenta and upstream non-template in bright green. The single 
stranded template nucleotides +1, +2 and +3 are colored orange, purple and cyan, respectively. The 
structure also highlights proline 20 in green and the upstream clamp that forms around the exiting 
upstream duplex with arrows pointing to regions of the pinky and thumb that interact with the RNA 
(from Gong and Peersen 2010). 
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incoming nucleotide. The product RNA exits as an upstream duplex through a clamp formed by 
the pinky and thumb domains of the polymerase.   
Through soaking experiments with cognate CTP and CTP analogs, the elongation 
complex was trapped in different stages of the overall catalytic cycle, thereby providing insight 
into the conformational changes associated with catalysis. The catalytic cycle proposed after 
analysis of the elongation complex showed the absence of a major nucleotide-repositioning step 
that is commonly seen in other polymerases. Rather, NTPs bind to an open conformation of the 
polymerase that closes for the subsequent catalysis via a subtle repositioning at the palm domain. 
The driving force for this conformational change arises from a shift in the palm domain that 
repositions Asp 233 to recognize the ribose of the NTP. This differs from other polymerase 
structures, which utilize large movements in the fingers domain. The lack of the NTP-
repositioning step reduces polymerase fidelity by removing a key step for selecting the 
appropriate nucleotide. This, in addition to the absence of a proofreading mechanism, may 
account for the rapid viral evolution that occurs in positive-sense RNA viruses. In addition, 
based on the structures from this study, the Peersen lab proposes a sixth step in the catalytic 
cycle of nucleotide incorporation constituting the translocation event.  
Viral RdRPs play an essential role in viral propagation and deserve our attention as a 
potential target for antivirals. By elucidating the mechanism and structure of this enzyme, we 
gain a better understanding of replication processes in general, as well as valuable information 
regarding the viral life cycle. Specifically this information may assist in the design of antivirals 




Chapter 2  
Role of Charge and Hydrophobic Residues in the  
Poliovirus Polymerase Elongation Complex 
2.1 Introduction 
Positive-strand RNA viruses encompass a wide range of serious human and animal pathogens 
that cause diseases including the common cold, liver disease, heart disease, meningitis, 
encephalitis, and paralytic poliomyelitis.  As a group, these viruses encode for and require a viral 
RNA-dependent RNA polymerase (RdRP) for genome replication. This process involves 
replication of the positive sense genome into a negative sense intermediate that in turn templates 
the replication of additional positive sense strands. These positive-sense strands are subsequently 
used for additional rounds of translation or packaged as genomic RNA into the forming virions.  
Viral RdRPs must form a stable and processive elongation complex (EC) to replicate the 
entire genome. Formation of this complex begins with RNA binding to form a polymerase-RNA 
complex, followed by a conformational change that poises the complex for incorporation of the 
first nucleoside triphosphate (NTP). After the addition of the first nucleotide, the complex 
undergoes another conformational change and converts to what is known as the elongation 
complex that is capable of rapidly replicating the viral genome. The rate limiting step of forming 
the elongation complex is followed by catalytic cycles for addition of each nucleotide. In this 
cycle, binding of the appropriate NTP to an open active site is followed by a conformational 
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change that closes the active site to allow for catalysis. After catalysis, the active site must 
reopen to allow for pyrophosphate release and subsequent translocation of the RNA. This results 
in an open post-translocation state capable of binding the next NTP. 
Structurally, viral RdRPs contain an approximately 55 kDa core that folds in a conformation 
resembling a cupped right hand with palm, thumb, and fingers domains (Thompson and Peersen 
2004). The finger domains reach across the palm domain to make interactions with the top of the 
thumb domain, encircling the active site and creating a loop that NTPs can be shuttled through 
for catalysis. This interaction between the fingers and thumb does not occur in other DNA- or 
RNA-dependent polymerase and serves to tether the two domains together.  Overall, this 
interaction prevents the two domains from undergoing large-scale independent movements. 
Many DNA- and RNA-dependent polymerases utilize large conformational changes in the 
fingers and thumbs to open and close the active site during catalysis. Viral RdRPs must rely on 
rearrangements in the palm domain to facilitate this motion (Gong and Peersen, 2010). The 
driving force behind the conformational changes comes from NTP recognition. Incoming 
nucleotides bind the active site through base pairing interactions with the +1 template nucleotide. 
The subsequent ribose hydroxyl recognition causes the structural rearrangement in the palm that 
enables catalysis to occur. This method for active site closure does not involve movements in the 
fingers domain (Gong and Peersen, 2010).   
Analysis of the poliovirus EC structure shows template RNA interacting with the fingers 
domain before reaching a conserved cleft between the pinky and index fingers that facilitates 
strand separation (Gong and Peersen, 2010). Although the structure shows definitive interactions 
between the polymerase and the first three base pairs of the downstream duplex, the interactions 
between the fingers domain of 3Dpol and additional downstream duplex are poorly defined. A 
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comparison of the fingers domain in the apo-3Dpol structure and the elongation complex structure 
reveals no key differences in conformation between the two (Thompson and Peersen, 2004; 
Gong and Peersen, 2010). However, evidence from a mutational analysis of Trp5 suggests the 
fingers domain plays a key role in interacting with downstream template RNA (Hobdey and 
Peersen, 2010). This provides evidence for possible interactions between the downstream RNA 
and the fingers domain of the polymerase.  
 In this study, we investigated the role of several basic and hydrophobic residues within 
the fingers domain of poliovirus polymerase in an attempt to characterize their role in RNA 
replication (Fig. 2.1). We analyzed the effect that mutations to these residues have on RNA 
binding, elongation complex formation rates, elongation rates, and elongation complex stability. 
The data show that charged residues have a significant role in binding RNA, while the mutations 
to the hydrophobic residues show no significant effect on binding. In contrast, the hydrophobic 
residues, especially Y118 and Y148, play key roles in forming a stable elongation complex. Both 
types of mutations displayed no effect on elongation rates, while both types of mutations 
demonstrated a significant decrease in the stability of the polymerase elongation complex.  
2.2 Material and Methods 
2.2.1 Mutant Generation and Protein Expression.  
3Dpol constructs were expressed from the pET26-UbDH plasmid that was obtained from the 
Cameron lab at Penn State University. This plasmid contains the complete open reading frame of 
the poliovirus 3Dpol gene sandwiched between an N-terminal ubiquitin (Ub) and a C-terminal 
GSSS-His6 tag (Gohara et al., 1999). Expression from this plasmid yields 3Dpol fused with 
ubiquitin. After in vivo translation, Ubp1, an ubiquitin-specific carboxyl-terminal protease that is 
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FIG 2.1 Structural overview of basic and hydrophobic residues. PV 3Dpol colored with the palm in grey 
and the thumb in blue while the index, ring and pinky fingers are in green, yellow and pink, respectively. A) 
Top view of the structure highlighting the four tyrosine residues mutated to alanines for this study. B) Top 
view of the structure highlighting the arginine and lysine residues mutated to alanines for this study. C) 
Tyrosine mutations in context of the PV elongation complex shown in magenta with RNA in orange. C) 
Lysine and arganines mutations in context of the PV elongation complex shown in magenta with RNA in 




co-expressed in E. coli pCGI cells, cleaves ubiquitin producing full-length 3Dpol with an 
authentic N-terminal that has glycine as the first residue (Gohara et al., 1999). In addition, the 
3Dpol gene contains a 3Dpol L446D point mutation that effectively disrupts the Interface I 
interaction allowing the polymerase to exist as a monomer (Hobson et al., 2001; Lyle et al., 
2002; Thompson and Peersen, 2004). 
The appropriate mutations were cloned into the pET26-UbDH plasmid using primers 
synthesized by Integrated DNA Technologies and designed for Quick-Change site-directed 
mutagenesis (Invitrogen). Mutations were verified through sequencing, which is performed by 
the Proteomics and Metabolics Facility at Colorado State University. The mutant clones were 
subsequently transformed into Escherichia coli BL-21 DE3 pCGI cells for expression. Colonies 
from the transformation were used to inoculate 5 mL LB media and grown at 37° C in the 
presence of 50 µg/mL kanamycin and 34 µg/mL chloramphenicol until the optical density at 
600 nm reached ~1.0. The culture were then used to inoculate 1L LB media and once again 
grown at 37°C and in the presence of 50 µg/mL kanamycin, but without chloramphenicol. Once 
the optical density at 600 nm reached ~0.5 the cells were cooled to room temperature and 
expression was induced through addition of IPTG to a final concentration of 0.4 mM. After an 
additional 14-18 hours of growth, the cells were pelleted through centrifugation at 4000 rpm in a 
model J-6 centrifuge (Beckman).  
2.2.2 Protein Purification. 
The resulting pellet from centrifugation were resuspended in lysis buffering consisting of 
50 mM Tris (pH 8.0), 300 mM NaCl, 20% (vol/vol) glycerol, and 0.02% (wt/vol) NaN3 and 
lysed at 18,000 lbs/cm2 in a model M-110L microfluidizer (Microfluidics). NP-40 was added to 
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the lysate in a drop-wise manner to a final concentration of 0.1% (vol/vol) followed by DNA 
precipitation through the addition of PEI to a final concentration of 0.25% (vol/vol). The solution 
was centrifuged at 17,000 rpm for 45 minutes in a Sorvall RC2-B centrifuge. The supernatant 
was filtered through a 0.2 micron cellulose acetate filter, loaded onto a HisTrap HP nickel 
column (GE Healthcare), and eluted with 350 mM imidazole in buffer containing 50 mM Tris 
(pH 8.0), 300 mM NaCl, 20% (vol/vol) glycerol, and 0.02% (wt/vol) NaN3. Fractions containing 
the polymerase were pooled and diluted three-fold in low salt buffer consisting of 50 mM NaCl, 
25 mM Tris (pH 8.5), 20% (vol/vol) glycerol, 0.02 (wt/vol) NaN3 to allow for loading onto a 
HiTrap Q HP column (GE Healthcare). Polymerase was eluted via a linear gradient of 50 mM to 
1 M NaCl, pooled and concentrated to a volume ~0.8 mL using 30 KDa MWCO centrifugal 
concentrator (Amicon) and a model 5810 R centrifuge (Eppendorf). The concentrated sample 
was loaded onto a Mono Q column (GE Healthcare) and eluted with a linear gradient using the 
same buffer conditions as for the Q-column. Fractions containing the polymerase were pooled, 
concentrated as before to a volume of ~0.8 mL, and loaded onto a Superdex 200 gel filtration 
column (GE Healthcare) equilibrated in 200 mM NaCl, 5 mM Tris (pH 7.5), 20% glycerol 
(vol/vol), and 0.02% (wt/vol) NaN3. Fractions containing the polymerase were pooled, provided 
5 mM TCEP, concentrated to a final [3Dpol] of 200 µM, flash frozen with liquid nitrogen, and 
stored at -80°C. Purification efficiency and sample purity were assessed by running samples 
from each step of the process on 12% acrylamide PAGE. 
2.2.3 RNA Oligonucleotides 
The RNA constructs used in all four assays were synthesized by Integrated DNA Technologies 
(www.idtdna.com). The two different oligonucleotides used in the binding assay and elongation 
rate study contain a 5’ fluorescein added by IDT. The constructs are suspended in TE buffer 
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(10mM Tris (pH 8.0), 1mM EDTA), heated to 95°C for three minutes, and snap cooled on ice to 
fold the RNA into the primer-template hairpin to allow for elongation. The RNA 
oligonucleotides used in the initiation and stability assays contain an amino modifier 
deoxythymidine residue within the loop of the RNA hairpin labeled with an IRdye 800RS NHS 
ester (LI-COR Biosciences) and folded into the primer-template form as described above. 
2.2.4 RNA Binding. 
RNA binding assays were performed using an “8-10” polymerase elongation template element 
(PETE) RNA consisting of an eight base pair (bp) hairpin followed by a ten-nucleotide (nt) 
template with a fluorescein labeled to the 5’end of the construct. 10 nM of RNA is mixed with 
50 mM Hepes (pH 6.5), 75 mM NaCl, 1.5 mM MgAc2, 60 µM ZnCl2, 4 mM dithiothreitol 
(DTT), and 0.1% (vol/vol) NP-40. 3Dpol was titrated into the RNA mix giving a range of protein 
concentrations from 1.0x10-8 M to 3.5 x10-5 M and incubated at 4°C for 30 minutes, followed by 
additional 30 minutes of incubation at room temperature. Fluorescence polarization (FP) was 
measured in a black 384-well polystyrene plate using a Perkin-Elmer Victor V multimode 
microplate reader. Using Kaleidagraph (Synergy Software), we constructed plots of FP versus 
[3Dpol], and fit the data to single-site binding isotherm with a Hill coefficient to determine RNA 
dissociation constants.  
2.2.5 Elongation Complex Formation.  
To determine the rate for elongation complex formation we employed two LI-COR labeled 
RNA constructs that allow for formation of either a +1 or +2 product in the same reaction. The 
10+1.12 PETE consists of a 10-bp hairpin primer, allows for incorporation of one nucleotide 
leading to a “locked” elongation complex, and leaves a 12-nt single-stranded template. The 
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9+2.24 PETE consists of a 9-bp hairpin primer, allows for incorporation of two nucleotides 
resulting in a “locked” elongation complex, and leaves a 24-nt downstream template. In addition, 
both RNA molecules lack a guanosine within the templating region until the sixth nucleotide 
from the 5’ end. This allows us to pause elongation by omitting CTP, thereby preventing the 
polymerase from reaching the end of the template and avoiding end effects. The RNA constructs 
were mixed to a final concentration of 0.5 µM each with 15 µM 3Dpol, 40 µM of each ATP and 
GTP in a reaction buffer consisting of 50 mM Hepes (pH 6.5), 75 mM NaCl, 1.5 mM MgCl2, 
and 5 mM TCEP. Reactions were quenched through equal volume mixing with quench buffer 
comprised of 50 mM Hepes, 75 mM NaCl, and 10 mM EDTA after various amounts of time. 
Samples were separated through gel electrophoresis on a 15% acrylamide, 7M Urea PAGE gel, 
analyzed with a LI-COR Odyssey infrared imager 9120, and quantified using Odyssey software. 
Plots of percent of total RNA elongated versus time were constructed using Kaleidagraph and fit 
to a single exponential curve providing an apparent Km.  
2.2.6 Elongation Rate.  
RNA elongation assays utilized the 10.26 PETE RNA that consists of a 10-bp hairpin and a 
26-nt template with a fluorescein attached to the 5’ end of the construct. 1 µM RNA was 
premixed with 15 µM 3Dpol, 40 µM ATP and incubated at room temperature for 30 minutes to 
allow formation of the locked +1 elongation complex in the same buffer conditions used for the 
elongation complex formation assay. The resulting solution was diluted 10-fold in reaction 
buffer and stored on ice until ten minutes prior to use, at which point the reaction was placed in a 
water bath set to 22.5°C. Using an applied Photophysics SX-20 stopped-flow instrument, the 
preformed elongation complex was rapidly mixed with an equal volume of the remaining 
nucleotides to allow for full elongation of the 10.26 RNA. The final solution measured in the 
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instrument contains 50 nM RNA, 750 nM 3Dpol, and a range of 5 µM-120 µM each NTP. 
Fluorescence excitation occurs at 492 nm from a monochromator source and emission was 
detected using a 515 nm high pass filter. From collecting the parallel and perpendicular polarized 
fluorescence, we calculated total fluorescence (TF) and fluorescence polarization (FP) as 
previously described (Gong et al., 2009). Using Kaleidagraph, the lag time was calculated by 
fitting an initial decrease and the final increase in signal to two independent single exponential 
curves. The intersection between these curves provides the amount of time to elongate through 
20-nt, which was used to calculate rate in nt/second. The rates were plotted against substrate 
concentration to construct a Michaelis-Menten curve enabling calculations of Vmax and Km.  
2.2.7 Elongation Complex Stability.  
Stability studies followed the protocol for elongation complex formation with the 9+2.24 
RNA, as outlined in section 2.2.4. Incubation times for complex assembly varied from 15 
minutes to 90 minutes to provide ample time for complex formation based on results from 
formation rate studies in Table 2.1. To prevent degradation during the room temperature 
incubation, RiboLock RNase Inhibitor (Fermentas) was added to 3 units/uL. The reaction was 
then diluted ten-fold in the complex formation buffer containing 300 mM NaCl instead of 
75 mM NaCl to prevent polymerase rebinding and 10+1.12 RNA at equivalent amounts as 
9+2.24 to serve as a degradation control. After various amounts of time, samples were mixed 
with an equal volume solution that provides 40 µM each of ATP, GTP, and UTP and incubated 
for an additional three minutes to allow for full elongation of the 9+2.24. Quench buffer (see 
2.2.4) was added to stop the reaction and samples were separated using PAGE for analysis. 
Again, Odyssey software was employed to image and quantitate the gel, and stability was 
assessed using Kaleidagraph to calculate the percent of elongated RNA out of total RNA.   
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2.3 Results 
2.3.1 Basic residues play role in RNA binding. 
To determine the ability of the mutated polymerases to bind a synthetic RNA construct we 
employed a fluorescence polarization based binding assay. Titration of wild type protein into a 
solution containing a 5’-fluorescein labeled RNA construct shows an increase in fluorescence 
polarization corresponding to a decrease in the fluorescein’s mobility in solution. From the data, 
we can construct a binding curve that yields an apparent disassociation constant (KD). The data 
show a wide range of reduced affinities, resulting from mutations to the basic residues 
(Fig. 2.2A). Mutation to alanine at residues K126 and K133 show only minor decreases in RNA 
affinity, while mutation at K125 shows a more severe decrease. The R188A mutation nearly 
abolished 3Dpol’s ability to bind RNA. In contrast, none of the mutations to the hydrophobic 
residues displayed significant changes in RNA binding affinity, indicating these residues do not 
play a direct role in binding the templating RNA during replication (Fig. 2.2B).  
Since mutations to the selected tyrosine residues showed no effect on polymerase RNA 
binding affinity, we tested whether these residues displayed any effect on RNA replication. 
Using another synthetic PETE RNA construct, we tested these mutants’ abilities to form fully 
elongated products after short incubation periods. The experiments showed that WT polymerase 
achieves full elongation after 15 minutes, while Y14A and Y157A show slowed kinetics, and 
Y118A and Y148A are almost devoid of elongation even after 25 minutes (Fig. 2.3). The data 
indicate that these hydrophobic residues have no direct effect on RNA binding, but do play some 


































































FIG 2.2 RNA binding results. Increase in fluorescence polarization upon addition of 3Dpol to reaction 
fluorescein labeled 8.10 PETE RNA. Kd values calculated from single binding site model fits to the 
sigmoidal binding curves can be found in Table 2.1. The ≈25 mM solubility limit of 3Dpol in these 
conditions prevented us from obtaining clear maximal binding plateaus at salt concentrations above 100 
mM for many of the mutants. To obtain RNA dissociation constants when curve fitting such data we fixed 
the maximal FP signal to the stable plateau value observed with wild type protein, allowing the fitting 
algorithm to vary only the starting FP value and the midpoint of the binding curve  (A) Comparison of wild-
type 3Dpol binding affinity with the mutations of basic residues. (B) Comparison of wild-type 3Dpol binding 
affinity with the mutations of tyrosine residues.  
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Table 2.1 Summary of biochemical data for PV 3Dpol mutants. NP indicates the assay was Not Performed 
on the given mutant. ND indicates the assay was performed, but produced No Data due to extreme effects 




0	  	  	  5	  	  15	  	  25	   0	  	  5	  	  15	  	  25	  0	  	  	  5	  	  15	  	  25	  0	  	  5	  	  15	  	  25	   0	  	  5	  	  15	  	  25	  
WT	   Y14A	   Y148A	  Y118A	   Y157A	  
FIG 2.3 Tyrosine residues play role in elongation. PV 3Dpol was incubated with a 10.26 PETE RNA 
consisting of a 10-bp hairpin primer and a 26-nt single-stranded template. Samples of the reaction were 
quenched after 5, 15, and 25 minutes and run over a 12% acrylamide 7 M urea gel. The gel shows the starting 
(S) material reaching a full-length (FL) product over time. Y14A and Y157A display slightly lower levels of 
activity, while Y118A and Y148A have greatly diminished activity.  
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2.3.2 Tyrosine Mutations slow EC formation rate. 
To assess the roles that the tyrosine residues play in elongation and to determine if the 
charged residues displayed additional effects, we examined the rate at which these mutants form 
the stable elongation complex. Once again we employed self-priming RNA PETE constructs, 
and measured the rate of incorporation of the first few nucleotides, as previously described 
(Hobdey et al.; 2010). The two RNA constructs are both added to the same reaction along with 
ATP and GTP. The shorter of the two constructs allows for incorporation of only guanosine 
while the longer of the two allows incorporation of both adenine and guanosine (Fig. 2.4A). This 
allows us to measure the rate at which a +1 or +2 elongation complex is formed. Data show 
slight decreases in the formation rates for Y14A and Y157A, while Y118A and Y148A show ten 
and thirty fold decreases in formation rates respectively (Fig. 2.4E). This significant decrease 
partially explains the decreased amount of full elongation seen previously (Fig 2.3).  
The mutations of basic residues also demonstrated a decrease in formation rate ranging from 
three to eight-fold (Fig. 2.4D). Since initiation as a whole entails RNA binding and incorporation 
of the first nucleotide, any effects on RNA binding will be apparent in this assay as well. 
Therefore, the diminished RNA affinities for the basic residues may provide an explanation for 
the reduced rates of EC formation. Indeed, the two values correlate very well, in that the mutants 
with higher disassociation constants also having slower initiation rates (Table 2.1). The control 
mutants K66A, K314A, and K431A displayed near WT activity for incorporation of the first one 
or two nucleotides (Fig. 2.4C).  
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FIG 2.4 Elongation complex formation results. (A) Cartoon of the polymerase elongation template element 
(PETE) RNA constructs used to determine the rate of elongation complex initiation. Nucleotide incorporation 
begins at the triangle and continues until reaching a templating GTP, six nucleotides from the end of the 
sequence. The asterisk marks the position the deoxythymidine residue is added to allow for imaging via an 
infrared fluorescence dye (B) Denaturing PAGE showing the formation of both the +1 and +2 products over 
time in minutes from the starting material (S) for both wild-type and an example of a slower mutant (Y148A). 
(C) Graph showing the formation of +2 complex over time. Comparison of the initiation rates for the +2  
product between wild-type and the control mutants, (D) charge mutants, (E) and tyrosine mutants. The time 
constants associated with each curve-fit are given in Table 2.1.  
A)	   B)	  
C)	   E)	  D)	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2.3.3 Elongation Rate not affected by mutations.  
To further dissect the effect of the tyrosine mutants, we performed experiments to determine 
the 3Dpol elongation rate using the PETE assay in stopped-flow kinetics studies. The RNA 
construct used for the elongation rate experiments consists of a ten base pair hairpin for self-
priming followed by a 26-nt templating region containing a 20-nt heterogeneous G-less cassette. 
The RNA is incubated with the first nucleotide for incorporation and then stalled at a +1 
elongation complex. Stopped-flow experiments mix the complex with the remaining nucleotides 
for full elongation and measure the amount of time required by the 3Dpol to reach the 5’-end of 
the RNA construct and restrict the mobility of the fluorescein. Data shows an initial lag phase 
corresponding to the incorporation of the first 20 nucleotides, comprising the G-less cassette, 
followed by a large increase in fluorescence polarization corresponding to the incorporation of 
the last five nucleotides (Gong et al., 2009). This data enable us to determine a rate measured in 
nucleotides per second. Once carried out at multiple NTP concentrations (Fig. 2.5A), we can 
analyze the data according to Michaelis-Menton kinetics to determine Vmax and apparent Km 
values to compare WT 3Dpol with the mutated polymerases. The data for wild-type polymerase 
matches previously published rate constants (Gong et al., 2009). In addition, the tyrosine mutants 
and control mutants also displayed near wild-type values for both the Vmax and apparent Km 
(Fig. 2.5B). This indicates these residues have no direct effect on 3Dpol elongation rates and 
confirms no direct effects on substrate affinity. Although the kinetics of the mutant polymerases 
matched those of wild-type 3Dpol, several of the stopped-flow traces showed a decrease in total 
fluorescence after reaching the maximum level while wild-type and the control mutants 
displayed no such drop in total fluorescence (Fig. 2.5C). This phenomenon was evident in all 

























































FIG 2.5 Elongation rate experiments. (A) Lag phase and the following increase in total fluorescence 
associated with the incorporation of the first twenty and last five nucleotides, respectively.  The length of 
the lag phase decreases as the [NTP] increases. (B) Michaelis-Menton plot comparing the maximum 
elongation rate and apparent Km of wild-type 3Dpol, control mutants, and tyrosine mutants. The calculated 
values for these enzymatic parameters are listed in Table 2.1. (C) Normalized total fluorescence of wild-
type, Y14A, and Y118A at 25uM NTP showing the differences in signal decay after reaching maximum 
total fluorescence. (D) Raw fluorescence anisotropy plots of wild-type, Y14A, and Y118A at 25uM NTP 
showing the differences in amplitude change and starting amplitude. The elongation curves starting with a 
lower initial fluorescence anisotropy also exhibit a smaller overall change in anisotropy, indicating that 




















































2.3.4 Mutations affect EC stability 
 To determine whether these residues played a role in stabilizing the elongation complex, we 
designed an experiment in which the 9+2.24 RNA was stalled in the +2 complex. The elongation 
complex is then diluted 10-fold with a buffer containing 300 mM NaCl to prevent rebinding of 
the polymerase to any released RNA. The diluted complex is incubated at room temperature for 
various amounts of time and then provided with the remaining nucleotides to elongate to a +20 
product. This allowed for measurement of the efficiency with which the pre-formed complex 
elongates to full-length product after a pause in the elongation cycle that correlates directly with 
the stability of the elongation complex. Data from these experiments for wild-type 3Dpol matches 
previously published results (Hobdey et al., 2010). In addition, the control mutants displayed 
comparable levels of stability to wild-type 3Dpol (Fig. 2.6A); however, all of the remaining 
mutations led to significant decrease in the stability of the elongation complex. The charged 
mutants all displayed a roughly 3-fold decrease in stability and Y14A and Y157A showed an 
approximately 8-fold decrease (Fig. 2.6B&C). Mutations to residues 118 and 148 severely 
affected the stability of the complex so that no full-length product was seen after only 5 minutes 
of incubation.  
2.4 Discussion 
In analyzing the role of residue 5 in the 3Dpol elongation complex, the Peersen lab proposed 
possible interactions between the downstream duplex RNA and Trp5 (Hobdey et al., 2010). 
Although this interaction has not been captured through crystallography studies, the templating 
RNA could possibly wrap around the fingers domain of the polymerase before entering the 


















































FIG 2.6 Elongation complex stability results. Percentage of RNA that forms full length product from a 
stalled elongation complex over time. (A) Comparison of the kinetic data for the stability of the +2  product 
over time between wild-type and the control mutants, (B) charge mutants, (C) and tyrosine mutants. The 
time constants associated with each curve-fit are given in Table 2.1.  
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interactions to facilitate wrapping of the RNA around the fingers domain. Along this channel are 
several basic residues that may form electrostatic interactions with the phosphate backbone of 
the incoming RNA. In addition, several tyrosine residues within this groove may stack with the 
bases of the single stranded RNA or facilitate other necessary interactions. Through a mutational 
study to select lysines, arginines, and tyrosines within this channel, we have assessed the 
importance of these residues in forming and stabilizing an elongation complex. This data is 
consistent with the hypothesis formulated from the Trp5 study that the downstream template 
RNA wraps around the polymerase and makes interactions with the fingers domain that serve in 
the preservation of the elongation complex.   
In characterizing the role of the residues along this putative RNA entry channel, we first 
tested whether elimination of the basic residues or large planar groups of the tyrosine residues 
affected RNA binding. The results show the tyrosine residues within the fingers domain have no 
direct effect on RNA affinity. In contrast, the mutations of the charged residues located within 
the pinky finger of 3Dpol diminished the affinity between protein and RNA. Since substitution of 
alanines for the tyrosine residues within the groove show no significant affects on binding, we 
conclude that even if the template RNA is interacting with these residues, that the interactions do 
not facilitate the initial binding event. On the other hand, since mutations to the basic residues 
within this channel did affect binding, we assume removal of the positively charge side chain 
disrupts electrostatic interactions between the pinky finger of 3Dpol and the negatively charged 
phosphate backbone of the incoming RNA. This becomes especially evident from the elongation 
complex structure, which shows residue R188 clearly forming a salt bridge with the -2 phosphate 
of the upstream duplex. Other residues, such as K133, make clear interactions with the phosphate 
backbone of the downstream template. Although the elongation complex structure does not show 
46
K125 and K126 making direct interactions with downstream RNA, they may serve a role in a 
more general electrostatic contribution to binding affinity.  
While the tyrosine residues lining this possible template RNA binding channel do not play a 
direct role in binding RNA, the results show that these residues, especially Y118A and Y148A, 
play a key role in forming and maintaining a stable elongation complex. By analyzing the 
initiation rate associated with forming either a +1 or +2 elongation complex using PETE RNA 
constructs, we determined the effects of the mutations on initiation. The drastic decrease in 
elongation complex formation rate from Y118A and Y148A indicates these residues clearly have 
some function in initiation. Although the data does not provide an answer for the direct role of 
the these two tyrosines, we propose these residues affect either an important conformational 
change or interact directly with the RNA in a manner not visible in the elongation complex 
structure. Both propositions may be associated with a possible cis-trans isomerization event 
associated with proline 119 (Andreotti, 2003). Such an event may serve to reposition Tyr118 for 
interaction with the templating RNA. In addition, these residues may simply have packaging 
properties that stabilize a local structural rearrangement from the isomerization event. Regarding 
Tyr157, the EC structure shows a stacking interaction with the ribose of the +2 nucleotide of the 
downstream RNA. Thus, we believe position 157 requires a planar residue that can 
accommodate this interaction. Finally, from the data and the associated structure, we cannot 
determine a specific role for Tyr14.  
In testing initiation rates, we found the basic residues also displayed a decrease in elongation 
complex formation; however, this may be a result of these mutants’ lowered binding affinity. 
Evidence for this comes from a proportional relationship between RNA affinity and formation 
rate. The mutants such as K126A and K133A have the highest affinity for RNA and are the 
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fastest charged mutants to form the stable elongation complex. In contrast, R188A is incapable 
of forming either the +1 or +2 product, but has an RNA dissociation constant of 170 µM, 
suggesting the inability to form an elongation complex arises from an inability to bind RNA 
since the binding event occurs first in the overall process of initiation.  
Data from the elongation rate experiments indicates the hydrophobic residues do not affect 
RNA elongation rates due to the wild-type values these mutants have for both Vmax and Km. 
Interestingly, the data from the stopped-flow kinetics does show some discrepancy between the 
tyrosine mutant and wild-type plots. Not only do we see a decrease in signal amplitude for some 
of the mutants, there is also a decrease in total fluorescence (TF) after the maximum TF is 
reached in the mutant traces, while the WT and control signals remain steady. These data suggest 
a possible decrease in stability of the elongation complex associated with the mutations. The 
smaller change in fluorescence anisotropy indicates fewer complexes in solution, and the 
decrease in TF, implies the complexes are disassociating after elongation. To test this, we 
expanded our initiation assay to enable us to evaluate EC stability and determine a half-life for 
the complex. From the data, Tyr118 and Tyr148 once again emerge as key residues for formation 
and maintenance of the stable EC. Mutations at either of these positions eliminates 3Dpol’s ability 
to fully elongate from a stalled position after only five minutes. While Y118A and Y148A stand 
out, all of the mutations, both charge and tyrosine mutants, showed significant decreases in 
stability. Since tampering with the structure of the fingers domain has definite implications on 
stability, we believe this domain plays a key role in maintaining the EC in the correct 
conformation for processive elongation. Although we lack structural insight into the exact role 
the fingers domain plays in stabilizing the polymerase during replication, the lack of 
conformational changes in this region between the original 3Dpol structure and the EC structure 
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indicates there may be an unknown conformational change that repackages this region. Such a 
structural rearrangement seems even more plausible when considering the initiation and stability 
data from this study.  
In conclusion, we have provided additional evidence supporting the hypothesis that the 
downstream template RNA interacts with the fingers domain before undergoing strand 
separation. Specifically, it appears several basic residues lining a channel that separates the pinky 
finger from the remaining fingers perform a role in binding the RNA. In addition, Tyr118 and 
Tyr148 have a critical role in forming and maintaining a stable elongation complex. Although, 
we currently have no structural evidence that provides insight regarding the exact role of these 
residues, we believe there is an additional conformation the polymerase can adopt that we have 
not captured. In this conformation, these residues may directly interact with the template RNA or 




Structure of a Coxsackievirus Polymerase Elongation Complex 
3.1 Introduction 
The structures of several viral polymerases have been solved, including those 
from poliovirus (PV) (Thompson and Peersen, 2004) and coxsackievirus B3 (CV) 
(Campagnola et al., 2008; Gruez et al., 2008).  Phylogenic analysis shows these two 
viruses are genetically closely related and, therefore, have highly homologous 
polymerases that differ in length by a single amino acid insertion in coxsackievirus. 
Indeed the two structures solved by the Peersen lab superimpose almost exactly and show 
no key differences in the overall structure (Fig. 3.1). Both polymerases fold according to 
the right hand analogy that includes palm, thumb, and fingers domains (Thompson and 
Peersen, 2004). The tip of the fingers domain reaches over the palm to make contacts 
with the tip of the thumb domain through a set of hydrophobic interactions. This 
interaction encloses the active site centered within the palm domain and creates a channel 
through which NTPs can be shuttled in for catalysis (Thompson and Peersen, 2004). In 
addition to the original PV 3Dpol and CV 3Dpol structures, the Peersen lab has recently 
solved the structure of the PV elongation complex (PVEC) (Gong and Peersen, 2010). 
The lab has developed an experimental system for assembling and purifying PV 
polymerase elongation complexes stalled after several rounds of nucleotide incorporation. 
This results in a highly stable complex paused in the replication cycle and poised for 
incorporation of the next nucleotide. After obtaining crystals of PVEC, soaking 
experiments with NTPs and various NTP analogs are performed to trap the polymerase in 
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FIG 3.1 Comparison of picornaviral polymerase structures. Superimpositions of poliovirus (pink) 
and coxsackievirus (green) apo polymerase structures to show the high similarity between the viral 
polymerases.   
51
different steps of the catalytic cycle.   Using this approach, the lab has solved several 
structures that capture PV 3Dpol in different stages of replication.  
The PVEC structure shows template nucleotides +1, +2 and +3 are single stranded 
with strand separation of the downstream duplex RNA occurring at residues 18 and 19 of 
the index finger (Fig. 3.2) (Gong and Peersen, 2010). The +2 nucleotide resides in a 
pocket formed by Pro 20 and the index finger that prevents it from base stacking with 
either the +3 or +1 nucleotides. The +1 nucleotide is positioned within the active site to 
allow for base stacking with the -1 upstream nucleotide of the priming base pair and base 
pairing with the incoming nucleotide triphosphate. The product RNA exits as an 
upstream duplex that is locked in place by a clamp formed by the pinky and thumb 
domains of the polymerase. Analysis of the structures obtained from the soaking 
experiments showed an absence of a nucleotide-repositioning step, common in other 
polymerases. Rather, NTPs bind to an open conformation of the polymerase that closes 
for the subsequent catalysis via a subtle repositioning at the palm domain. This 
conformational change causes a shift in the palm domain that repositions Asp 233. This 
differs from other polymerase structures, which utilize large movements in the fingers 
domain (Gong and Peersen, 2010).  
The experimental approach used to obtain crystals employs RNA constructs 
comprised of a 10mer primer annealed to a 35mer template strand with four nucleotides 
incorporated, resulting in a complex containing both upstream and downstream RNA 
duplexes (Fig. 3.2A) (Gong and Peersen, 2010). The upstream product strands coaxially 
stack with each other and form a set of crystal packing interactions (Fig. 3.2B). The RNA 
constructs all contain a pair of helical segments with an intervening templating sequence. 
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FIG 3.2 Poliovirus 3Dpol-RNA elongation complex structure. (A) The poliovirus polymerase is 
colored with the palm in grey and the thumb in blue while the index, middle, ring and pinky fingers are 
in green, orange, yellow and pink, respectively. The structure shows the template RNA strand in cyan, 
downstream non-template strand in magenta and upstream non-template in bright green. The single 
stranded template nucleotides +1, +2 and +3 are colored orange, purple and cyan, respectively. The 
structure also highlights proline 20 in green and the upstream clamp that forms around the exiting 
upstream duplex with arrows pointing to regions of the pinky and thumb that interact with the RNA 
(from Gong and Peersen 2010). (B) The figure shows the staggered coaxial stacking interactions 
between the upstream template-product duplexes of two different elongation complexes (A+E and I
+M) in context of the unit cell with dimensions a, b, and c. Again the template strand is in cyan, the 




By varying the length of the coaxially stacked product and non-stacked template regions, 
the complexes may stack differently with one another and crystallize in different forms 
(Gong and Peersen, 2010).  
In this work, we utilize the experimental approach developed by Gong and 
Peersen to crystallize a stalled coxsackievirus polymerase elongation complex (CVEC). 
Before attempting to crystallize the CVEC, we employed the kinetic assays from the PV 
mutagenic studies (Chapter 2) to establish that CV could efficiently form and maintain a 
stable elongation complex. To produce diffracting crystals, we synthesized variations of 
the RNA used to assemble the elongation complex that produced the PVEC structure by 
inserting or deleting sequence surrounding the core RNA construct (Fig 3.3). The ensuing 
crystallographic work produced four complete data sets with resolution at 2.75Å or better 
in two different crystal forms (C2 and P1). The CVEC structure from the crystal in the 
C2 space group closely resembles the PVEC structure, showing few differences. 
However, the crystal in the P1 space group produced a CV elongation complex trapped in 
intermediate state of translocation. This P1 CVEC structure displays key differences from 
the PVEC structure and the C2 CVEC structure, thereby providing insight to mechanism 
of nucleotide translocation in the replication cycle.  
3.2 Material and Methods 
3.2.1 Protein Expression and Purification 
For this work, the CV 3Dpol gene was inserted into the pET26-UbDH plasmid used for 
making mutations to basic and tyrosine residues in PV 3Dpol and described in section 
2.2.1.  The resulting plasmid contains the complete open reading frame of the 
coxsackievirus 3Dpol gene sandwiched between an N-terminal ubiquitin (Ub) and a 
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FIG 3.3 RNA constructs for EC assembly. The v4-1 RNA construct (00) that produced the original 
PVEC structure was modified to produce eight new constructs all containing the same core sequence 
with nucleotides added or removed from the template region to vary the overall length. Both the v4-1 
and v5-1 constructs contain an 8-bp upstream duplex, allow for incorporation of 4-nt and form a 6-bp 
downstream duplex (8-4-6). To make variations of v5-1, nucleotides can be removed from the 
upstream duplex (v5-2 and v5-3) or added to the template region allowing for incorporation of 
additional nucleotides (v5-4 through v5-7). The v5-8 construct resembles the v5-1, but lacks 
downstream duplex (Figure from Peng Gong).  
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C-terminal GSSS-His6 tag (Gohara et al., 1999). Using Escherichia coli BL-21 DE3 
pCGI cells, CV3Dpol was expressed as described in section 2.2.1. After obtaining pellets 
from expression, we followed a purification protocol utilizing generally higher salt 
concentrations in later steps for CV 3Dpol due to solubility concerns. Pellets were 
resuspended in lysis buffering consisting of 50 mM Tris (pH 8.0), 400 mM NaCl, 20% 
(vol/vol) glycerol, and 0.02% (wt/vol) NaN3 and lysed at 18,000 lbs/cm
2 in a model 
M-110L microfluidizer (Microfluidics). NP-40 was added to the lysate in a drop-wise 
manner to a final concentration of 0.1% (vol/vol) followed by DNA precipitation through 
the addition of PEI to a final concentration of 0.25% (vol/vol). The solution was 
centrifuged at 17,000 rpm for 45 minutes in a Sorvall RC2-B centrifuge. The supernatant 
was filtered through a 0.2 micron cellulose acetate filter (Amicon), loaded onto a HisTrap 
HP nickel column (GE Healthcare), and eluted with 350 mM imidazole in buffer 
containing 50 mM Tris (pH 8.0), 400 mM NaCl, 20% (vol/vol) glycerol, and 0.02% 
(wt/vol) NaN3. Fractions containing the polymerase were pooled and diluted four-fold in 
low salt buffer consisting of 50 mM NaCl, 25 mM Tris (pH 8.5), 20% (vol/vol) glycerol, 
0.02 NaN3 to allow for loading onto a HiTrap Q HP column (GE Healthcare). Polymerase 
was eluted as 2 mL fractions via a linear gradient of 50 mM to 1 M NaCl into tubes 
containing 50 uL of 5 M NaCl and pooled. The resulting sample was diluted in low salt 
buffer to bring the [NaCl] below 125 mM and loaded onto a Mono Q column (GE 
Healthcare). Elution into 1 mL fractions was performed with a linear gradient using the 
same buffer conditions as for the Q-column into tubes containing 25 uL of 5 M NaCl 
bringing the salt concentration to approximately 400 mM. Fractions containing the 
polymerase were pooled, concentrated to a volume of ~0.8 mL, and loaded on to a 
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Superdex 200 gel filtration column (GE Healthcare) equilibrated in 300 mM NaCl, 5 mM 
Tris (pH 7.5), 20% glycerol (vol/vol), and 0.02% (wt/vol) NaN3. Fractions containing the 
polymerase were pooled, provided 5 mM TCEP, concentrated to a final [3Dpol] of 200 
µM, flash frozen with liquid nitrogen, and stored at -80°C. Purification efficiency and 
sample purity were assessed by running samples from each step of the process on 12% 
acrylamide PAGE. 
3.2.2 RNA Synthesis and Preparation 
The RNA constructs were made through a series of PCR reactions to produce a 
DNA template used in a large-scale in vitro T7 transcription as previously described 
(Kieft and Batey, 2004; Batey and Kieft, 2007; Gong and Peersen, 2010). The primers 
used in the series of PCR reactions were synthesized by IDT, purified by 12% acrylamide 
7M urea gel electrophoresis, excised from the gel, and isolated with an Elu-Trap electro-
elution device (Whatman Inc.). Primers were designed to anneal to each through an 18-25 
nucleotide overlap in the first PCR reaction, generating a product containing the sequence 
of interest (Fig 3.4A). In a simultaneous reaction using a parental plasmid pRAV23 
provided by the Kieft lab at the University of Colorado, a PCR reaction produces the 
glmS ribozyme (Fig 3.4A). Products from the two PCR reactions were combined in a 
third PCR reaction producing a DNA template containing a T7 promoter followed by the 
RNA sequence, cleavage site, and glmS ribozyme (Fig 3.4A&B).  
To generate full-length RNA, the PCR product was incubated for 3 hours in an 
8 mL T7 RNA polymerase reaction containing 60 mM Hepes (pH 7.8), 2 mM 
spermidine, 0.01% (vol/vol) Triton X-100, 15 mM DTT, 22 mM MgCl2, 4 mM each 
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FIG 3.4 Production of RNA constructs for EC assembly. A) Schematic of the three PCR reactions 
used to generate DNA template for T& transcription. Reaction 1a utilizes two primers synthesized by 
IDT that contain an 18-25 nucleotide overlap to produce the RNA sequence of interest. Reaction 1b 
utilizes pRAV23 as a template to produce the glmS ribozyme. Reaction 2 fuses the two first round 
products producing the template for transcription. B) 1% agarose gel with ethidium bromide staining 
showing the relative lengths of the three PRC products. C) 12% acrylamide 7 M urea gel with pre- and 
post-cleavage samples for each of the duplex RNA constructs. The gel shows uncut (U) samples 
containing full length RNA (FL) and cut (C) samples with the glmS ribozyme separated from the final 
product (FP).  
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precipitant through centrifugation, the transcription reaction was incubated at 65°C for 
three minutes and slowly cooled to room temperature to fold the glmS ribozyme into the 
catalytically active form. Addition of glucosamine-6-phosphate and NaCl to final 
concentrations of 5 mM and 100 mM, respectively, followed by a 30 minute incubation at 
42°C constitutes the glmS ribozyme self-cleavage reaction, generating the RNA product 
(Fig 3.4C). To purify the RNA, the cleavage reaction was run on a 12% acrylamide 7 M 
urea gel, excised from the gel, and isolated with an Elu-Trap electro-elution device 
(Whatman Inc.). Purified RNA undergoes a self-annealing reaction driven by a 5 minute 
incubation at 95°C followed by a snap-cooling event on ice to fold the RNA in the 
appropriate form. The final RNA product was stored at -80°C in RNA annealing buffer 
(RAB) composed of 5 mM Tris (pH 7.5), 50 mM NaCl, and 5 mM MgCl2. Using this 
approach, nine different RNA constructs were assembled with sequence variation 
outlined in Figure 3.4.  
3.2.3 EC Assembly, Purification, and Crystallization 
To prepare the RNA for elongation complex assembly, a 10-nt RNA primer was 
added to product RNA at 20% molar excess and annealed during a 5 minute incubation at 
42°C in RAB. The assembled RNA was mixed with purified 3Dpol to final concentrations 
of 15 µM and 20 µM, respectively, in a reaction buffer containing 50 mM Hepes (pH 
6.5), 75 mM NaCl, 5 mM MgCl2, 2 mM TCEP, and 450 µM of each ATP and GTP. The 
2 mL reaction was incubated at 22.5°C for 20 minutes and then purified over a MonoQ 
column (GE Healthcare) using a linear salt gradient from 75 mM to 1 M NaCl in buffer 
containing 50 mM Hepes (pH 6.5), 5 mM MgCl2, 2 mM TCEP, and 0.02% NaN3. The 
purified elongation complex was buffer exchanged into complex buffer (20 mM Hepes 
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(pH 6.5), 100 mM NaCl, 2 mM MgCl2, 2 mM TCEP) and concentrated to 8 mg/mL 
through centrifugation. 
Crystallization conditions were screened using nine different RNA constructs 
generated by varying primer sequences in the PCR reactions described in section 3.2.2 
and the Cryos Suite screening kit (Qiagen). Crystal trays were set up using a Douglas 
Instruments Oryx-8 robot to produce a 0.8 uL drops that were incubated at 16°C to allow 
for crystal growth by sitting drop vapor diffusion. Successful crystals were harvested and 
frozen in mother liquor with liquid nitrogen.  
3.2.4 Diffraction Data Collection and Reduction 
Crystals were sent to the Advanced Light Source in Berkeley, CA. Diffraction 
data was collected using the Molecular Biology Consortium synchrotron beam line 4.2.2, 
which was fully operated by remote control from Colorado. To ensure a complete dataset, 
187° of data were collected in 0.5° increments. The diffraction data was integrated, 
merged, and scaled using the d*Trek software suite. The output files (.ref) are converted 
to the appropriate form (.mtz) to obtain electron density maps using the CCP4 suite of 
programs. To obtain a model for molecular replacement, we superimposed the apo-CV3D 
(pdb file 3DDK) with the PVEC structure (pdb file 3OL6) and deleted both the PV 
polymerase and the portions of the upstream and downstream RNA that did not match the 
RNA construct that produced CVEC crystals. Superimposition was centered on residues 
320-335 of the PV3Dpol sequence (residues 321-336 of CV3Dpol). Using Phenix, we 
performed molecular replacement to obtain an initial model and electron density map.  
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3.3 Results 
3.3.1 CV3D Kinetic Assays 
 To ensure coxsackievirus would also efficiently form a stable elongation complex 
that will remain active for several hours, we employed the same assays used in the PV3D 
mutagenic studies (Section 2.2.5). Using both the 10+1.12 and 9+2.24 RNA constructs, 
we found the CV3D formed full-length product at approximately the same rate as the PV 
polymerase (Fig. 3.5A and Table 3.1). In addition, the CVEC demonstrates comparable 
levels of stability, evident from the continued elongation to full-length product of the 
9+2.24 after extended amounts of time (Fig. 3.5B and Table 3.1). In fact, the CVEC 
appears to be slightly faster in forming the +2 complex and more stable upon the 
formation of the +2 complex than the corresponding PVEC.  
3.3.2 CV 3Dpol Elongation Complex Structure 
 By screening nine different RNA constructs with a cryos suite screening kit from 
Qiagen, we obtained and harvested approximately 50 crystals from multiple conditions 
(Fig. 3.6). Of the crystals, four (mk022, mk040, mk042, mk050) gave complete high-
resolution data sets that yielded structures (Table 3.2). All four crystals came from 
elongation complex containing the v5-1 RNA construct (Fig. 3.3) but produced two 
different crystal forms (C2 and P1), from two different conditions (Table 3.2). The two 
structures in the C2 space group match the original PVEC structure in the catalytically 
open conformation, showing the polymerase trapped after incorporating four nucleotides. 
The fingers and thumb domains form a clamp around the upstream duplex as it exits the 
active site. To accommodate the product RNA, both domains must move outward as 
compared to the apo polymerase structure (Fig. 3.7). In addition, template binding forces 
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FIG 3.5 Comparison of PV3Dpol and CV3Dpol kinetics. A) Initiation rate. Percentage of RNA 
forming a +2  elongation complex over time using the 9+2_24 (Data for +1 formation not shown). 
CV3Dpol (red) initiates slightly faster than PV3Dpol (blue).  B) EC Stability. Graph shows the 
percentage of RNA that forms full length product from a stalled elongation complex over time. 
CV3Dpol (red) remains stable for longer than PV3Dpol (blue). Both graphs indicate both polymerase are 
highly capable of forming and maintaining a stable elongation complex.  
Table 3.1 Comparison of PV3Dpol and CV3Dpol Kinetics. Values for all three columns correspond to 
time in minutes. The numerical values are obtained from the graphs above (Initiation rate for the +1 
EC is not shown).  
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Table 3.2 Crystallographic data and refinement statistics. Crystals are numbered in the order they 
are harvested. Data in parenthesis corresponds to highest resolution shell. No structural refinement data 
available for mk042 and mk050  because they have not yet been processed.   
FIG 3.6 Coxsackievirus Elongation Complex Crystals. Crystals produced from elongation complex 
containing the v5-1 RNA construct. Shown here are just a few of the approximately 50 crystals 
harvested throughout the screening of all nine RNA constructs.  
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FIG 3.7 Comparison of the CV 3Dpol apo structure and elongation complex. The apo CV3Dpol 
structure (green) superimposed with the elongation complex structure (blue). Three main structural 
changes occur including outward movements of the fingers and thumb domain to accommodate RNA 
substrate. Also, Gly211 moves downward to prevent steric clash with the template strand. 
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Gly211 down towards the palm to make room for the RNA and prevent any steric 
clashes. The structure also shows downstream RNA feeding into the active site; however, 
the weak electron density prevented modeling of the downstream duplex. Therefore, we 
see only three unpaired template nucleotides entering the active site at the same location 
shown in the PVEC structure. Strand separation occurs at a conserved cleft comprised of 
residues 18 and 19 of the fingers domain. The +3 and +2 bases have Pro20 wedged 
between them, preventing stacking between the bases and the +1 base stacks with the 
template product duplex, as observed in the PVEC (Fig 3.8).  
3.3.3 CVEC Translocation Intermediate 
Along with the CVEC structure solved in the C2 space group, we obtained two 
crystals that captured the CVEC in a possible translocation intermediate. The structure, 
solved in the P1 space group, shows the template RNA shifted backwards from the active 
site relative to the PVEC structure and the C2 CVEC structure (Fig. 3.9).  The template 
RNA in the PVEC structure (Fig. 3.9A&B) and the C2 CVEC structure (Fig. 3.9C) 
superimpose almost perfectly, with base stacking interactions occurring between the -1 
and +1 bases and the +2 nucleotide shifted up into a small pocket. The P1 CVEC 
structure shows the -1 base still base pairing with the newly incorporated base of the 
product strand; however, the +1 base has shifted away from the active site (Fig. 3.9D). 
This backsliding of the template RNA prevents the stacking interaction between the -1 
and +1 bases and places the +1 base in the pocket that is normally occupied by the +2 
base (Fig. 3.9E). Furthermore, the RNA backsliding displaces the +2 base further from 
the active site so that it resides in essentially the +3 position of the PVEC and C2 CVEC 
structures (Fig. 3.9E). 
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FIG 3.8 Comparison of the CVEC and PVEC structures. The CVEC structure (cyan) superimposed 
with the PVEC (purple) with RNA in yellow and red, respectively. The structures show only minor 
differences in both the protein and RNA. The PVEC structure shows the downstream duplex (top) that 
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B)	  
FIG 3.9 RNA backsliding in the CV Translocation Intermediate. A) Active site of the 
poliovirus polymerase elongation complex (PVEC) with the template RNA strand in cyan and 
upstream non-template in bright green. The active site is colored magenta, and several key 
residues that facilitate catalysis are highlighted by numbering. Finally, the -1,+1, and +2 
positions of the template RNA are numbered. (Gong and Peersen, 2010) B) Active site of the 
PVEC in same orientation as panel (A). The EC is colored grey with the exception of the -1 
(red),+1 (yellow), and +2 (green) bases of the template RNA and the active site (magenta). C) 
Active site of the coxsackievirus polymerase elongation complex (CVEC) in the C2 form. D) 
Active site of the CVEC in the P1 form. E) Superimposition of panels B-D showing the 
alignment of the PVEC and CVEC in the C2 form and backsliding that occurs in the P1 form 
of the CVEC. 
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  Template RNA backsliding in the P1 CVEC structure also causes shifts of the 
phosphate backbone relative to the surrounding protein structures. In both the PVEC 
structure and the C2 CVEC structure, Thr114 of the pinky finger resides between the -1 
and +1 phosphates of the template RNA (Fig. 3.10A). The P1 CVEC structure shows 
Thr114 sitting between the -2 and -1 phosphates (Fig. 3.10B). This repositioning occurs 
due to the template RNA backsliding and causes the protein backbone surrounding 
Thr114 to shift downward to maintain the position of Thr114 in the middle of the 
surrounding phosphates (Fig. 3.10C). This occurs because the phosphate backbone does 
not shift by an entire nucleotide register during backsliding.  
3.3.4 CVEC Crystal Soaks 
We also performed soaking experiments in an attempt to trap the elongation 
complex in different stages of the catalytic cycle, as was done in the PV studies.  Soaking 
crystals produced by conditions 90 and 96 of the Qiagen screening kit with CTP or 
ddCTP caused the crystals to dissolve almost instantly. Other crystals remained intact 
upon the addition of CTP or various nucleoside analogs; however, after a short amount of 
time the crystals showed severe cracks that made them unworthy of harvesting. Finally, 
four crystals both remained intact and suffered only minimal damage due to soaking and 
were subsequently harvested for diffraction. However, these crystals gave only weak 
diffraction, and therefore were not processed any further.  
3.4 Discussion 
 The Peersen lab recently developed an experimental approach for obtaining 
crystals of viral polymerases stalled several nucleotides into replication. Using this 
method, they produced the structure of the poliovirus polymerase elongation complex 
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FIG 3.11 Thr114 as a possible translocation gate. The coxsackievirus polymerase 
elongation complex active site with the -2 (purple), -1 (red),+1 (yellow), and +2 (green) bases 
of the template RNA and Thr114 (blue) highlighted. A) Active site of the CVEC in the C2 
form showing Thr114 positioned between the -1 and +1 phosphates (spheres) of the template 
RNA. B) Active site of the CVEC in the P1 form showing Thr114 positioned between the -2 
and -1 phosphates (spheres) of the template RNA. C) Superimposition of panels A-B, 
illustrating the distortion of the protein backbone to maintain the position of Thr114 directly 
between two phosphates. Also, the differences in the positions of the RNA are readily scene.  
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(PVEC) capturing the polymerase with extensive upstream and downstream RNA (Gong 
and Peersen, 2010). The structure reveals key information regarding the interactions 
between the polymerase and the RNA. In addition, by soaking crystals with cognate CTP 
and various analogs, they were able to trap the complex in different stages of the overall 
catalytic cycle, thereby gaining insight into the conformational changes associated with 
replication. Of special significance, they determined the polymerase switches back and 
forth between open and closed conformations (Gong and Peersen, 2010). To complement 
this research, we utilized the same experimental approach in an attempt to produce the 
structure of the coxsackievirus polymerase elongation complex (CVEC). Results 
generated not only a CVEC structure comparable to the initial PVEC structure, but also 
the structure of a possible translocation intermediate. Comparison of these two structures 
with each other and the PVEC structures yields important information regarding 
picornaviral polymerase structure-function relationships.  
 Before carrying out crystallographic experiments, we assessed the kinetics of 
CV 3Dpol using the initiation and stability assays employed to characterize the role of 
basic and hydrophobic residues in PV3Dpol (Chapter 2). The results show the two viral 
polymerases exhibit relatively the same rates in both assays. The similarity in kinetics 
demonstrates the evolutionary conservation between these two viruses and their 
associated proteins. Since the data indicates CV 3Dpol forms and maintains an elongation 
complex very efficiently it suggests the CVEC could potentially crystallize utilizing the 
same method designed for the PVEC structure.  
 In addition to the similarities found in the kinetic data, the structures of the PVEC 
and CVEC are highly homologous as well. Both structures display the same outward shift 
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of the fingers and thumb domains and the downward movement of Gly211 in order to 
accommodate RNA substrate (Gong and Peersen, 2010).  Furthermore, the pathways of 
the template RNA into the active site and the upstream duplex through the clamp formed 
by the fingers and thumbs domain are nearly identical between the two structures. The 
high homology shared between these viral polymerase elongation complexes further 
demonstrates the evolutionary conservation between these two viruses. Furthermore, the 
success of the experimental approach used to obtain both structures suggests this method 
may provide structures of other viral RNA-dependent RNA polymerases. 
 Along with the kinetic data and the C2 CVEC structure, results from this project 
yielded an elongation complex trapped in a possible translocation intermediate. The P1 
CVEC structure shows the template RNA shifted backwards from the active site relative 
to the C2 CVEC structure. This RNA backsliding causes a shift in both the location of the 
bases surrounding the active site and the phosphate backbone. Although the RNA in the 
P1 CVEC structure appears to have moved backwards relative to the existing PVEC 
structures and the C2 CVEC structure, we believe this may represent a complex trapped 
in a pre-translocation state. In other words, the P1 CVEC structure may show the position 
of the template RNA before translocation occurs, so that translocation causes the +1 base 
to swing down from the pocket above the active site into a position that allows for base 
stacking with the -1 base. This allows the incoming nucleotide to not only base pair with 
the +1 base of the template strand, but also base stack with the -1 base of product strand 
(Gong and Peersen, 2010). Thus, we believe this structure represents a biologically 
relevant conformation that normally exists in equilibrium with the previously captured 
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states. During translocation the RNA would move from the position observed in the P1 
structure to the position seen in the C2 structure.  
 In addition, the observation that the phosphate backbone moves past Thr114 in 
the P1 CVEC structure to accommodate the RNA backsliding provides some evidence 
that this residue of the pinky finger may serve as a translocation gate. Again, we believe 
the P1 CVEC structure represents the state of the RNA before it moves into the position 
observed in the C2 CVEC structure. The phosphate group of the -1 base moves past 
Thr114 to allow for the +1 phosphate to move downward causing the +1 base to swing 
down into the active site for catalysis. Therefore, Thr114 appears to serve as the speed 
bump of translocation.  
 In conclusion, the comparison of the two CVEC structures with each other and the 
PVEC structures has confirmed many of the findings from the poliovirus studies while 
simultaneously providing insight into the mechanism of translocation. This information 
serves to increase our understanding of viral polymerases and may assist in the 
production of antiviral pharmaceuticals targeting the RNA-dependent RNA polymerase 
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